Bids Are Invited For Price Registration For Future Acquisitions Of Cardiovascular System Medicines, With Aim To Meet The Demands Of Ipesaude Units, In Accordance With The Technical Specifications Contained In Annex I – Terms Of Reference Of This Notice.

Acetazolamide - Concentration/Dosage 250 Mg, Tablet Pharmaceutical Form, Vial Presentation Form, Oral Route Of Administration, Acetylsalicylic Acid - Concentration/Dosage 100 Mg, Adenosine - Concentration/Dosage 3 Mg/ 2 Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form, Presentation Form Intravenous Administration, Alteplase - Concentration/Dosage 1 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Presentation Form Ampoule Vial + 50Ml Diluent, Intravenous Administration Via, 12/09/2025 - 10:27:58, Amiodarone, Hydrochloride - Concentration/Dosage 50 Mg/Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form With 3Ml, Intravenous Administration Route, Hydrochloride - Concentration/Dosage 200 Mg, Tablet Presentation Form, Atenolol - Concentration/Dosage 50 Mg, Oral Administration Route, Atenolol - Concentration/Dosage 25 Mg, Atorvastatin Calcium - Concentration/Dosage 10 Mg, Pharmaceutical Form Coated Tablet, Atropine, Sulfate - Concentration/Dosage 0.25 Mg/Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form With 1Ml, Bisoprolol - Concentration/Dosage 2.5 Mg, Bisoprolol - Concentration/Dosage 5 Mg, Captopril - Concentration/Dosage 25 Mg, Carvedilol - Concentration/Dosage 6, 25 Mg, Oral Administration Route, Carvedilol - Concentration/Dosage 3, 125 Mg, Blister Presentation Form, Carvedilol - Concentration/Dosage 12, Clonidine, Hydrochloride - Concentration/Dosage 150 Mcg/Ml, Pharmaceutical Form, Injectable Solution, Parenteral, Intrathecal Or Epidural Route Of Administration, Hydrochloride - Concentration/Dosage 0, 150 Mg, 100 Mg, Clopidogrel, Bisulfate - Concentration/Dosage 75 Mg, Deslanoside - Concentration/Dosage 0, 2 Mg/Ml, Ampoule Presentation Form With 2Ml, Intravenous Or Intramuscular Route Of Administration, Digoxin - Concentration/Dosage 0, Diltiazem, Hydrochloride - Concentration/Dosage 30 Mg, Dobutamine, Hydrochloride - Concentration/Dosage 12.5 Mg/Ml, Ampoule Presentation Form 20 Ml, Dopamine, Hydrochloride - Concentration/Dosage 5 Mg/Ml, Ampoule Presentation Form With 10 Ml, Intravenous Administration Route, Enalapril - Concentration/Dosage 10 Mg, Enalapril - Concentration/Dosage 5 Mg, Epinephrine - Concentration/Dosage 1 Mg/Ml, Administration Route Intramuscular, Intravenous And Subcutaneous, Esmolol, Hydrochloride - Concentration/Dosage 10 Mg/Ml, Vial-Ampule Presentation Form, Spironolactone - Concentration/Dosage 100 Mg, Spironolactone - Concentration/Dosage 25 Mg, Etilefrine, Ampoule Presentation Form With 1 Ml, Intramuscular And Subcutaneous, Furosemide - Concentration/Dosage 40 Mg, Formade Tablet Presentation, Furosemide - Concentration/Dosage 20 Mg/Ml, Intravenous And Intramuscular Administration Route, Hydralazine, Hydrochloride - Concentration/Dosage 20 Mg, Injectable Solution, Ampoule With 1Ml, Packed According To The Product Registration And With Price, Date Of Manufacture And Expiry, Route Of Administration Intramuscular / Intravenous, Hydrochloride - Concentration/Dosage 25 Mg, Drug, Oral Route Of Administration, Hydrochlorothiazide - Concentration/Dosage 25 Mg, Isosorbide, Mononitrate - Concentration/Dosage 20 Mg, Pharmaceutical Form Capsule Or Tablet, Dinitrate - Concentration/Dosage 5 Mg, Sublingual Administration Route, Losartan, Potassium - Concentration/Dosage 50 Mg, Oral Administration Route, Methyldopa - Concentration/Dosage 250 Mg, Methyldopa - Concentration/Dosage 500 Mg, Metoprolol, Tartrate - Concentration/Dosage 1Mg/Ml, Presentation In Ampoule With 5Ml, Via De A